Lupin has launched Prucalopride tablets in the US following USFDA approval. The bowel disorder treatment enters a $184 million market and will be manufactured at the company’s Goa facility.
Lupin has launched Prucalopride tablets in the US following USFDA approval. The bowel disorder treatment enters a $184 million market and will be manufactured at the company’s Goa facility.